Compass Therapeutics (NasdaqCM:CMPX) FY Conference September 08, 2025 11:00 AM ET Company ParticipantsSara Nik - VP & Equity Research - BiotechThomas Schuetz - Co-Founder, Director & CEOSara NikOkay, good morning everyone, and welcome to our next session. I'll be your moderator, Sarah Nick, an Equity Research VP at H. C. Wainwright. And it's my pleasure to introduce our next presenter, Thomas Schutz, CEO of Compass Therapeutics, a clinical stage oncology focused pharmaceutical biopharmaceutical company focu ...